FIELD: chemistry. ^ SUBSTANCE: present invention pertains to alpha-2A/alpha-1A selective agonist, which is a compound with formula , as well as to a pharmaceutical composition, which contains a pharmaceutical carrier and a therapeutic effective quantity of alpha-2A/alpha-1A selective agonist, which contains a compound with structure 1. ^ EFFECT: obtaining selective agonist which can be used for preventing or alleviating neurological conditions without an accompanying sedative effect during extraneous administration. ^ 6 cl, 2 tbl, 2 ex, 2 dwg
NON-SEDATIVE A-2-AGONIST 1-(2,3-DIMETHYL-PHENYL)-ETHYL-1,3-DIHYDRO-IMIDASOLE-2-THIONE